On January 1, 2024, Olon Ricerca Bioscience LLC and Olon USA Inc. joined forces. This merger and rebranding as Olon…
The end of a year brings with it an opportunity for reflection and learning in which we take pride in…
Oftentimes, in the pursuit of cost-effective and efficient manufacturing solutions, pharmaceutical development companies find themselves grappling with unforeseen challenges when…
In the pharmaceutical research and development space, intellectual property (IP) infringement can inflict substantial damage on companies. Just one substantial…
Investment of EUR 10 million in the industrial site in Rodano (Milan), Olon’s headquarters, with 50 new jobs, aimed at…
In the rapidly evolving world of pharmaceuticals and biotechnology, business development plays a crucial role in forging successful partnerships, creating…
Milan, Italy – November 09, 2023 – Olon Group, a world leader in the production of APIs, announces a multi-year…
It has been an outstanding CPHI for Olon, it achieved an incredible success at 2023 Global Generic and Biosimilar Awards…
On the occasion of CPhI Worldwide 2023 (Barcelona, 24 – 26 Oct), the most important international event of the chemical-pharmaceutical…